Tag Archives: CBK

Top 5 Undervalued Stocks To Buy For 2019

We look for high quality dividend stocks with strong competitive advantages and shareholder friendly managements trading at fair or better prices, explains Ben Reynolds, editor of Sure Dividend.

Cardinal Health (CAH) — a healthcare services and products company operating in the pharmaceutical and medical sectors — underperformed the market by more than 20% in 2016. 

The company’s stock price fell due to intense pricing pressure within the pharmaceutical distribution industry.  That trend is set to reverse in 2017. 

Cardinal Health is a Dividend Aristocrat with a 2.5% dividend yield.  The stock has increased its dividend payments for 32 consecutive years. 

What immediately stands out about Cardinal Health is its low P/E ratio. The stock is trading for an adjusted P/E ratio of 14. 

Its average P/E ratio over the last 3 years is 20.  The stock appears significantly undervalued — and it has excellent growth prospects. 

Top 5 Undervalued Stocks To Buy For 2019: Intercontinental Hotels Group(IHG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about InterContinental Hotels Group (NYSE:IHG) has been trending positive this week, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. InterContinental Hotels Group earned a daily sentiment score of 0.37 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.1342951063181 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Ethan Ryder]

    Playa Hotels & Resorts (NASDAQ: PLYA) and InterContinental Hotels Group (NYSE:IHG) are both consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability.

  • [By Max Byerly]

    Shares of InterContinental Hotels Group PLC (NYSE:IHG) have been given an average recommendation of “Hold” by the eight brokerages that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $66.00.

  • [By Ethan Ryder]

    InterContinental Hotels Group PLC (NYSE:IHG) has received a consensus recommendation of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating on the company. The average 12 month target price among analysts that have covered the stock in the last year is $66.00.

  • [By Logan Wallace]

    Shares of Intercontinental Hotels Group (LON:IHG) have been given a consensus rating of “Hold” by the twelve ratings firms that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is GBX 4,483.33 ($58.40).

  • [By Stephan Byrd]

    INTERCONTINENTAL HOTELS GROUP Common Stock (LON:IHG)‘s stock had its “neutral” rating restated by equities researchers at JPMorgan Chase & Co. in a research report issued on Wednesday.

Top 5 Undervalued Stocks To Buy For 2019: Christopher & Banks Corporation(CBK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Warburg Research set a €8.80 ($10.35) target price on Commerzbank (ETR:CBK) in a report issued on Monday morning. The firm currently has a neutral rating on the financial services provider’s stock.

  • [By Logan Wallace]

    Independent Research set a €9.50 ($11.05) target price on Commerzbank (ETR:CBK) in a report published on Thursday morning. The brokerage currently has a neutral rating on the financial services provider’s stock.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Christopher & Banks (CBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Commerzbank AG (ETR:CBK) have been assigned an average recommendation of “Hold” from the twenty ratings firms that are currently covering the company, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is €10.98 ($12.76).

  • [By Shane Hupp]

    Cfra set a €9.50 ($11.05) price target on Commerzbank (ETR:CBK) in a report released on Wednesday. The firm currently has a neutral rating on the financial services provider’s stock.

Top 5 Undervalued Stocks To Buy For 2019: On Assignment Inc.(ASGN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Insperity (NYSE: NSP) and ASGN (NYSE:ASGN) are both mid-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on ASGN (ASGN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    ASGN (NYSE: ASGN) and Amn Healthcare Services (NYSE:AMN) are both mid-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

Top 5 Undervalued Stocks To Buy For 2019: ESSA Bancorp, Inc.(ESSA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News coverage about ESSA Bancorp (NASDAQ:ESSA) has been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ESSA Bancorp earned a news sentiment score of 0.03 on Accern’s scale. Accern also assigned headlines about the financial services provider an impact score of 46.7822985822929 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Shane Hupp]

    ESSA Bancorp, Inc. (NASDAQ:ESSA) insider Gary S. Olson sold 2,298 shares of ESSA Bancorp stock in a transaction that occurred on Tuesday, October 2nd. The stock was sold at an average price of $16.25, for a total transaction of $37,342.50. The transaction was disclosed in a filing with the SEC, which is available through this link.

  • [By Logan Wallace]

    ESSA Bancorp, Inc. (NASDAQ:ESSA) CEO Gary S. Olson sold 1,365 shares of the business’s stock in a transaction dated Thursday, August 23rd. The shares were sold at an average price of $16.21, for a total value of $22,126.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Top 5 Undervalued Stocks To Buy For 2019: Penumbra, Inc.(PEN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Penumbra Inc (NYSE:PEN) insider James Robert Pray sold 8,125 shares of the business’s stock in a transaction that occurred on Monday, July 30th. The stock was sold at an average price of $138.34, for a total value of $1,124,012.50. Following the completion of the transaction, the insider now directly owns 1,578 shares in the company, valued at $218,300.52. The sale was disclosed in a legal filing with the SEC, which is available through this link.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Penumbra (PEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Penumbra (NYSE:PEN) Director Bridget O’rourke purchased 700 shares of the business’s stock in a transaction that occurred on Friday, May 25th. The stock was bought at an average cost of $156.40 per share, for a total transaction of $109,480.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

  • [By Stephan Byrd]

    Penumbra Inc (NYSE:PEN) insider Daniel Donen Davis sold 7,500 shares of the firm’s stock in a transaction that occurred on Monday, August 27th. The stock was sold at an average price of $130.38, for a total transaction of $977,850.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Hot Blue Chip Stocks To Watch For 2019

Timing the market is easily one of the most difficult parts of trading. In particular, calling the market bottom and knowing when to get in is usually something investors only know way after the fact. 24/7 Wall St. is looking back to when the S&P 500 bottomed back in March 2009 to see how some of the major blue chips have fared since then.

Back on March 6, 2009, the S&P 500 bottomed out at 666.79, and from there began perhaps the biggest bull market of the modern era. At the most recent close, the S&P 500 was at 2,779.60, more than quadrupling its bottom nearly nine years ago.

So how does this measure up against AT&T Inc. (NYSE: T)?

On an adjusted close basis, AT&T closed March 6, 2009, at $13.82 a share, or at $22.58 on an unadjusted basis. AT&T most recently closed at $36.87 on an adjusted basis.

Looking at the numbers, we can see that AT&Ts growth over this nine-year period was outpaced by the S&P 500 and the broad markets in general. This is one of the few instances where the market beat a blue chip in this period. Specifically, the telecom giant saw its shares gain just over 165%.

Hot Blue Chip Stocks To Watch For 2019: Christopher & Banks Corporation(CBK)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dollar Tree, Inc. (NASDAQ: DLTR) is expected to report quarterly earnings at $1.23 per share on revenue of $5.56 billion.
    Express, Inc. (NYSE: EXPR) is projected to report quarterly loss at $0.02 per share on revenue of $466.25 million.
    Dollar General Corporation (NYSE: DG) is estimated to report quarterly earnings at $1.4 per share on revenue of $6.20 billion.
    Tech Data Corporation (NASDAQ: TECD) is expected to report quarterly earnings at $1.46 per share on revenue of $8.13 billion.
    Burlington Stores, Inc. (NYSE: BURL) is estimated to report quarterly earnings at $1.09 per share on revenue of $1.49 billion.
    Ciena Corporation (NYSE: CIEN) is projected to report quarterly earnings at $0.3 per share on revenue of $726.56 million.
    American Eagle Outfitters, Inc. (NYSE: AEO) is expected to report quarterly earnings at $0.22 per share on revenue of $806.17 million.
    Titan Machinery Inc. (NASDAQ: TITN) is estimated to report quarterly loss at $0.08 per share on revenue of $276.27 bmillion.
    Donaldson Company, Inc. (NYSE: DCI) is projected to post quarterly earnings at $0.52 per share on revenue of $682.68 million.
    Ship Finance International Limited (NYSE: SFL) is expected to report quarterly earnings at $0.21 per share on revenue of $92.08 million.
    Perry Ellis International, Inc. (NASDAQ: PERY) is projected to report quarterly earnings at $0.67 per share on revenue of $232.30 million.
    Kirkland's, Inc. (NASDAQ: KIRK) is estimated to report quarterly loss at $0.09 per share on revenue of $140.83 million.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) is expected to report quarterly earnings at $0.18 per share on revenue of $90.20 million.
    J.Jill, Inc. (NYSE: JILL) is projected to report quarterly earnings at $0.19 per share on revenue of $160.50 million.
    Christopher & Banks Corporation (NYSE: CBK) is expected to report quarterly loss at $0.08 per share on revenue of $89.35 million.
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Christopher & Banks (CBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Commerzbank AG (ETR:CBK) have been assigned an average recommendation of “Hold” from the twenty ratings firms that are currently covering the company, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is €10.98 ($12.76).

  • [By Joseph Griffin]

    Christopher & Banks Co. (NYSE:CBK) reached a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $0.75 and last traded at $0.81, with a volume of 12488 shares changing hands. The stock had previously closed at $0.89.

Hot Blue Chip Stocks To Watch For 2019: PICO Holdings Inc.(PICO)

Advisors’ Opinion:

  • [By Shane Hupp]

    PICO (NASDAQ: PICO) and Urban Edge Properties (NYSE:UE) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

  • [By Joseph Griffin]

    Pico (NASDAQ: PICO) and Ellington Financial (NYSE:EFC) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, dividends, valuation, earnings, profitability and analyst recommendations.

  • [By Ethan Ryder]

    NEW WORLD Dev L/ADR (OTCMKTS: NDVLY) and Pico (NASDAQ:PICO) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership and profitability.

Hot Blue Chip Stocks To Watch For 2019: Seaspan Corporation(SSW)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Shares of Seaspan Corporation (NYSE:SSW) rallied 15% last month thanks to a bullish analyst note.

    So what

    Seaspan’s stock bobbed around the flatline for most of April until an analyst at Deutsche Bank upgraded the containership leasing company from hold to buy toward the end of the month. What stood out was the $13 price target, which was 85% above the bank’s previous one of $7 a share. Driving that bullish view is the expectation that Seaspan’s ability to deleverage its balance sheet and increase the dividend would fuel substantial share price appreciation in the future.

  • [By Shane Hupp]

    SEASPAN Corp/SH SH (NYSE:SSW) hit a new 52-week high during trading on Tuesday . The stock traded as high as $10.47 and last traded at $9.97, with a volume of 33824 shares. The stock had previously closed at $10.07.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on SEASPAN Corp/SH SH (SSW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    That helps to explain why shares of Seaspan Corporation (NYSE:SSW) and Diana Shipping (NYSE:DSX) are up 36% and 28%, respectively, since the beginning of April. Both performances easily beat the 5% return of the S&P 500 in that span. However, even the healthy gains made recently don’t come close to erasing the losses accumulated in recent years, as both shipping leaders are down over 34% in the last three-year period.

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

Hot Blue Chip Stocks To Watch For 2019: Envestnet, Inc(ENV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Zillow (NASDAQ: ZG) and Envestnet (NYSE:ENV) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

  • [By Ethan Ryder]

    Envestnet Inc (NYSE:ENV) insider Shelly O’brien sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, June 4th. The stock was sold at an average price of $54.23, for a total value of $216,920.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

  • [By Dan Caplinger]

    Financial services companies rely on the health of the markets to bring them business from the large institutions that are their best customers. With a bull market that’s almost a decade long at this point, Wall Street has never been stronger, and that’s given a big boost to financial information technology specialist Envestnet (NYSE:ENV). Yet as volatility returns to the stock market in early 2018, some investors feared that Envestnet’s time in the sun might soon end and give way to more difficult conditions looking ahead.

Hot Blue Chip Stocks To Watch For 2019: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Casey Wilson]

    Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

  • [By Keith Speights]

    In October 2017, I predicted that Insys Therapeutics (NASDAQ:INSY) could be the biggest comeback story of 2018.For a while, it looked like I was on the right track. Insys stock soared in the fourth quarter of 2017. By early January, it was one of the hottest marijuana stocks on the market. Then the momentum evaporated.

  • [By Taylor Cox]

    FDA/Biotech

    INSYS Therapeutics, Inc (NASDAQ: INSY) FDA AdCom meeting for Buprenorphine

    Investor Events

    Analyst/investor days for: Sanmina Corporation (NASDAQ: SANM), Walgreens Boots Alliance, Inc (NASDAQ: WBA) and Xilinx, Inc (NASDAQ: XLNX)
    IPO quiet period expires for Zuora, Inc (NYSE: ZUO)
    Analyst quiet period expiration for DocuSign, Inc (NASDAQ: DOCU)

    Wednesday

  • [By Joseph Griffin]

    These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get Insys Therapeutics alerts:

    Chemotherapy Induced Nausea and Vomiting – Pipeline Insight, 2018 Market Report; Launched via MarketResearchReports.com (digitaljournal.com) Insys Therapeutics (INSY) Presents At Jefferies 2018 Global Healthcare Conference – Slideshow (seekingalpha.com) Insys Therapeutics (INSY) Expected to Announce Quarterly Sales of $27.32 Million (americanbankingnews.com) INSYS Therapeutics, Inc. (INSY)- Price to Book (P/B) Ratio in the Limelight (nasdaqfortune.com) INSYS Therapeutics to Present at Jefferies Global Healthcare Conference (globenewswire.com)

    Shares of NASDAQ:INSY traded up $0.09 during mid-day trading on Monday, reaching $6.96. The stock had a trading volume of 19,958 shares, compared to its average volume of 602,835. The company has a market capitalization of $507.07 million, a P/E ratio of -14.20 and a beta of 1.09. Insys Therapeutics has a 1 year low of $4.10 and a 1 year high of $14.00.

  • [By Keith Speights]

    What aboutInsys Pharmaceuticals (NASDAQ:INSY)? The biotech’s lead product is an opioid drug, but it also has an approved cannabinoid drug on the market for treatinganorexia in people with AIDS who have lost weight, and chemotherapy-induced nausea and vomiting. Insyshas a couple of experimental pain drugs in its pipeline — but none of them are cannabinoids. The company’s lead cannabinoid candidate targets childhood absence epilepsy, infantile spasms, genetic disorder Prader-Willi syndrome — but not pain.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Insys Therapeutics (INSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Low Price Stocks To Watch Right Now

Stocks finished the week lower as oil prices fell and the Federal Reserve looks set to raise interest rates next week.

Agence France-Presse/Getty Images

The S&P 500 fell 0.4% this week after rising 0.3% to2,372.60 today, while the Dow Jones Industrial Average dropped 0.5% this week after advancing44.79 points, or 0.2%, to20,902.98 today. The Nasdaq Composite dipped 0.2% this week after gaining 0.4% to5,861.73 today.

The S&P 500 and the Nasdaq Composite snapped six-week winning streaks, while the Dow ended a four-week winning streak.

Wellington Shields’ Frank Gretz notes that the “market is supposed to be anticipatory.” He explains:

Opinions follow price memories do as well. If higher prices alone were not enough, the news always seems to improve as prices move higher. After all, the media always needs to explain the higher prices, and the good therefore becomes the emphasis. For example, theres little talk of the all-but-certain pending rate hike. Since the election the market has had a remarkable run, one built more on policy hope than policy reality. This complaint is met with the retort that it has only been 50 days, or whatever. Fair enough, but the point remains. Then, too, the market is supposed to do this, its supposed to be anticipatory. Investors are getting this, and hence, what has been persistent strength. Interestingly, investors will begin to believe they always got it no one was really worried about a possible trade war, and so on. The psychologist Baruch Fischhoff called this creeping determinism, the idea that unexpected events turn into the expected. In other words, we will remember being more bullish in November than we were.

Hot Low Price Stocks To Watch Right Now: BioScrip, Inc.(BIOS)

Advisors’ Opinion:

  • [By Shane Hupp]

    BioScrip (NASDAQ: BIOS) and Amedisys Home Health and Hospice Care (NASDAQ:AMED) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.

  • [By Money Morning News Team]

    BioScrip Inc.(Nasdaq: BIOS) provides at-home medical care and services across the United States.

    BIOS’s central profit opportunity is in the rapid growth of the pharmaceutical industry. The pharmaceutical market is currently worth $12 billion and is expected to grow at an annual rate of five to seven percent.

  • [By Chris Lange]

    BioScrip, Inc. (NASDAQ: BIOS) saw its shares make a solid gain on Tuesday after another analyst issued a positive rating on the stock. Lake Street Capital initiated its coverage with a Buy rating and a $4.50 price target. This is implying an upside of over 300% from the previous closing price of $1.04.

  • [By Chris Lange]

    On Tuesday, BioScrip Inc. (NASDAQ: BIOS) reported third-quarter financial results before the markets opened. The company said that it had a net loss of $0.09 per share and $224.5 million in revenues. The consensus estimates from Thomson Reuters had called for a net loss of $0.05 per share and revenues of $223.26 million. The same period of last year reportedly EPS of had $0.04 and $247.22 million in revenues.

Hot Low Price Stocks To Watch Right Now: Performant Financial Corporation(PFMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Performant Financial Corporation (NASDAQ: PFMT) were down 29 percent to $2.20. Performant Financial is expected to release Q1 earnings on May 8.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

Hot Low Price Stocks To Watch Right Now: Medley Capital Corporation(MCC)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Lee Jackson]

    Medley Capital Corp. (NYSE: MCC) is another company that had the man at the top buying shares. CEO Brook Taube added 188,336 shares of the business development company at prices that ranged from $7.13 to $7.48 per share. The total for the trade was posted at $1 million. The stock closed Friday at $7.26.

Hot Low Price Stocks To Watch Right Now: Christopher & Banks Corporation(CBK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Christopher & Banks Corporation (NYSE: CBK) got a boost, shooting up 24 percent to $1.50 after the company reported strong preliminary revenue for the third quarter.

  • [By Lisa Levin]

    Christopher & Banks Corporation (NYSE: CBK) shares were also up, gaining 40 percent to $2.64. Christopher & Banks reported a Q4 loss of $0.24 per share on revenue of $94.6 million. The company projects Q1 revenue of $93 million to $98 million.

Hot Low Price Stocks To Watch Right Now: Foundation Medicine, Inc.(FMI)

Advisors’ Opinion:

  • [By Todd Campbell]

    Technology stocks are staples in growth portfolios because of their eye-popping revenue growth, but technology isn’t the only sector of the stock market that boasts fast-growing companies. For example, many healthcare stocks are growing at rates that Silicon Valley would envy. In fact, Foundation Medicine (NASDAQ:FMI), Exelixis Corp (NASDAQ:EXEL), and Teladoc (NYSE:TDOC) all reported year-over-year sales growth north of 100% in first-quarter 2018.

Hot Low Price Stocks To Watch Right Now: Career Education Corporation(CECO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Career Education Co. (NASDAQ:CECO) – Equities researchers at Piper Jaffray reduced their Q2 2018 earnings per share estimates for shares of Career Education in a note issued to investors on Thursday, May 3rd. Piper Jaffray analyst P. Appert now expects that the company will post earnings per share of $0.19 for the quarter, down from their previous forecast of $0.24. Piper Jaffray also issued estimates for Career Education’s Q3 2018 earnings at $0.23 EPS, Q4 2018 earnings at $0.29 EPS, FY2018 earnings at $0.95 EPS, Q1 2019 earnings at $0.28 EPS, Q2 2019 earnings at $0.25 EPS, Q3 2019 earnings at $0.29 EPS, Q4 2019 earnings at $0.34 EPS, FY2019 earnings at $1.16 EPS and FY2020 earnings at $1.26 EPS.